Axsome Therapeutics

$30.0M revenue • 200 employees • 1 World Trade Center 29th floor, New York, NY, 10007, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

Axsome Therapeutics

Address

1 World Trade Center 29th floor, New York, NY, 10007, United States

Website

axsome.com

Approx. Annual Revenue

$30.0M

Employees

200

Established

2011

About Axsome Therapeutics

Axsome Therapeutics is a pharmaceutical company headquartered in New York, United States, with approximately 201 employees. The company is focused on developing innovative treatments for central nervous system (CNS) conditions, including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia. Axsome's current pipeline includes several investigational drug candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14, which are in various stages of clinical development.

Business Profile

Read from the Axsome Therapeutics website on Oct 27, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current news and product information; Clear navigation and investor resources
Footer copyright year
2026

Biotech & Life Sciences Companies near New York, NY

Browse all Biotech & Life Sciences companies in New York →

Frequently Asked Questions about Axsome Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

Matt Wade General Manager
Herriot Tabuteau Chief Executive Officer
LinkedIn
Michelle Baladi Executive Director, Clinical Development
LinkedIn
Jim Mahoney Senior Clinical Research Associate
LinkedIn
Abby Ansah Clinical Research Associate II
LinkedIn